NEW YORK (GenomeWeb) – Affymetrix today announced through its subsidiary, eBioscience, that the firm has entered into a multi-year distribution agreement with Birmingham, UK-based diagnostic tools supplier The Binding Site.
Under this agreement, The Binding Site has been granted the exclusive rights to distribute eBioscience clinical flow cytometry reagents in the clinical care market, including hospitals and reference labs.
"Our best-in-class full ASR and CE designated immunology and oncology antibody portfolio is a natural complement to the expertise of The Binding Site," Dara Grantham Wright, senior vice president of the eBioscience business at Affymetrix, said in a statement. "With this agreement we strengthen our emphasis on addressing the needs of the growing cancer diagnostics market."
The Binding Site began servicing US customers on Dec. 1 and will start to service customers outside the US on Feb. 15, 2015. The firm supplies reagents and instruments for in vitro diagnostics around the world.
Financial details of the agreement were not disclosed.